Who invested in Expedition Therapeutics?
Expedition Therapeutics's investors include Venrock, RA Capital Management, General Atlantic, Novo Holdings and Vivo Capital, and 2 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$280Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
From Expedition Therapeutics's own website: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Expedition Therapeutics's investors include Venrock, RA Capital Management, General Atlantic, Novo Holdings and Vivo Capital, and 2 more on record.
Expedition Therapeutics has raised $280M across 2 rounds since 2025.
Expedition Therapeutics's most recent round was a Series B of $115M in Aug 2026.
Expedition Therapeutics's largest round on record is $165M (Series A), in Oct 2025.
Expedition Therapeutics's first round on record, in Oct 2025, was backed by Venrock, Novo Holdings and Forbion Capital Partners and 1 others.
Expedition Therapeutics's latest named round is a Series B, in Aug 2026.
Expedition Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.